Pediatric Vaccines Market: Granular View of The Market from Various End-Use Segments
Lately, the global pediatric vaccination market has been exhibiting a robust growth. The rise in initiatives by various governments to spread awareness regarding child healthcare, coupled with increasing investments, is propelling the global market to a significant extent. Various upcoming child healthcare programs by UNICEF and the WHO are likely to boost this market in the near future.
The worldwide pediatric vaccine market is broadly analyzed on three fronts: products, technology, and types of diseases. The markets for CNS drugs, pediatric vaccines, pediatric hormones, anti-infective drugs, and allergy and respiratory drugs are the major segments of the global pediatric vaccines products market. On the basis of technology, this market is classified into live attenuated vaccines, dendritic cells vaccines, synthetic vaccines, inactivated vaccines, toxoid vaccines, conjugate vaccines, subunit vaccines, and recombinant vector vaccines. Infectious diseases, allergy, and cancer are the key segments of the pediatric vaccine market, based on the types of diseases. The market for infectious diseases is further divided into MMR, polio, pneumococcal disease, meningococcal disease, influenza, DTP, hepatitis, varicella, and rotavirus. North America, Europe, Asia Pacific, and the Rest of the World are the key regional markets for pediatric vaccines in the global arena.
This research report on the global pediatric vaccine market has been prepared after extensive research by experts at TMR. It presents a comprehensive analysis of this market on the basis of its current as well as historical performance. Growth drivers, restraints, and opportunities, along with prevalent trends and future prospects, have also been discussed at length in this report.
Request a PDF of Brochure @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=429
Overview of the Global Pediatric Vaccines Market
The global market for pediatric vaccines has reported an impressive development in its market valuation, thanks to the increasing rate of birth globally. The rising incidence of diseases such as polio, influenza, hepatitis has also fueled demand from the global pediatric vaccines market to a great extent.
The pediatric vaccines segment dominates the global pediatric vaccine products market. The market for live attenuated vaccines has registered the highest growth among all the segments, based on technology. By diseases, the infectious diseases segment has occupied the leading position at present. However, the rising prevalence of cancer, specifically Leukemia, in kids is projected to register the fastest growth in this market in the coming years. This will further boost the global market for pediatric vaccines in the near future.
North America leads the global market for pediatric vaccines and is closely followed by Europe. However, the market for pediatric vaccines in Asia Pacific is likely to report the fastest growth during the period from 2012 to 2018 owing to the high birth rate in China and India.
Though the growth prospects for the global market for pediatric vaccines looks lucrative, low accessibility to vaccines in developing economies, together with strict regulations for the usage of these vaccines, is likely to hamper the growth of this market over the next few years.
Companies mentioned in the research report
GlaxoSmithKline is the leading vaccine manufacturer in the global pediatric vaccine market, thanks to its blockbuster influenza vaccines, Hiberix and Fluvarix
Other prominent players operating in worldwide market for pediatric vaccine are Pfizer, Merck, Sanofi Pasteur, Crucell, Janssen, Bharat Biotech, Kaketsuken, Panacea Biotec, Baxter, Zydus Cadila, Nuron, S K Chemicals, Dynavax Technologies, Serum Institute of India, Bharat Immunologicals and Biologicals, Lupin, Indian Immunologicals, Novartis, LG Life Sciences, Shenzhen Kangtai Biological Products, Sinovac Biotech, Bavarian Nordic, Bio Med, AstraZeneca, bioCSL, Valeant Pharmaceuticals, Takeda Pharmaceutical, and Mitsubishi Tanabe Pharma.
Pre Book Full Report Now @ https://www.transparencymarketresearch.com/checkout.php?rep_id=429<ype=S